Aethlon Medical treats first subject with Hemopurifier device in Australia
"Aethlon Medical treats first subject with Hemopurifier device in Australia" was originally created and published by Medical Device Network, a GlobalData owned brand.
Targeted Oncology20h
Response Time and BRAF Status Factor Into IO Selection for Melanoma
During a Case-Based Roundtable® event, Thach-Giao Truong, MD, discussed how data from the CheckMate-067 and RELATIVITY-047 ...
precisionmedicineonline21h
Opdivo, Yervoy Outperform Single-Agent Immunotherapy in First-Line MSI-High, dMMR Colorectal Cancer
Data presented at the ASCO Gastrointestinal Cancers Symposium showed the regimen may be a new option, but it comes with more treatment and financial toxicity.
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Treats First Patient In Australian Hemopurifier® Cancer Trial
Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious ...
Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains On Cancer Clinical Trial Update
( MENAFN - Investor Ideas) Investorideas ( ), a go-to platform for big investing ideas for stock traders, including biotech and medical tech Stocks reports on trading and news for Aethlon Medical, Inc ...